Search CommunityWalk:
Create_a_map_small
Mymaps_small



Blank

Biological Mimetics, Inc.

Address:
124 Byte Drive
--
Frederick, MD 21702, USA
1-301-620-7565

Category: Biotechnology/Biopharmaceutical - Vaccines

Used in the following map:

Maryland Biotech Industry Map

Biological Mimetics, Inc. (BMI) is a biotechnology company that commercializes the pharmaceutical products which improves the quality of life and overall state of public health by combating resistant and emerging diseases in human and veterinary medicine. It was founded in 1996 by Peter L. Nara and George Lin. The company's mission is to remain a creative and innovative biotechnology firm dedicated to improving the quality of life and overall state of public health through the application of novel technologies for the development and commercialization of human and veterinary biologics to address a long list of hitherto intractable disease targets involving viruses, bacteria, parasites, and cancer.

Biological Mimetics' technologies include: Deceptive Imprinting and Immune Dampening and Refocusing. Its Deceptive Imprinting is a common strategy by which many disease pathogens and cancer cells evade conventional vaccine strategies as well as host immune responses. The company's proprietary, platform technology of Immune Dampening and Refocusing is a method that defeats antigenic variation and deceptive imprinting. Its technology has the potential to generate vaccines against pathogens for which no effective vaccine exists, improve on the limited protection of previously tried human and veterinary vaccines, and develop therapeutic vaccines that can be given after the onset of disease to supplement the natural response of the immune system. The company's technology is able to alter the natural antigenicity and immunogenicity of targeted protein antigens for vaccine purposes. The identification of novel therapeutic antibodies using Immune Dampening and Refocusing can be done in infectious disease and oncology applications.

Biological Mimetics' research and development is focused on the development of vaccines for Human Applications- Influenza Virus, Rhinovirus, Non-typeable Haemophilus Influenza, etc; and Veterinary Applications- Foot and Mouth Disease Virus, Infectious Pancreatic Necrosis Virus, and Porcine Reproductive and Respiratory Syndrome Virus.